GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001067) » Definitions » Payments of Debt

JW Pharmaceutical (XKRX:001067) Payments of Debt : ₩-241,371 Mil (TTM As of Sep. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Payments of Debt?

JW Pharmaceutical's Payments of Debt for the three months ended in Sep. 2024 was ₩-27,937 Mil.

JW Pharmaceutical's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-241,371 Mil.


JW Pharmaceutical Payments of Debt Historical Data

The historical data trend for JW Pharmaceutical's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Payments of Debt Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -158,874.77 -169,308.25 -98,658.13 -177,004.40 -316,231.74

JW Pharmaceutical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72,680.64 -140,666.59 -42,967.85 -29,800.00 -27,936.68

JW Pharmaceutical Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-241,371 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JW Pharmaceutical Payments of Debt Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines